We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

239 hedge funds and large institutions have $1.24B invested in Pacira BioSciences in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 67 increasing their positions, 95 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

374% more call options, than puts

Call options by funds: $3.13M | Put options by funds: $661K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

23% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 30

3% more funds holding

Funds holding: 233 → 239 (+6)

2% more capital invested

Capital invested by funds: $1.21B → $1.24B (+$28.4M)

2.41% less ownership

Funds ownership: 109.17% → 106.76% (-2.4%)

29% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 95

Holders
239
Holders Change
+6
Holders Change %
+2.58%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
37
Increased
67
Reduced
95
Closed
30
Calls
$3.13M
Puts
$661K
Net Calls
+$2.47M
Net Calls Change
-$2.36M

Top Buyers

1
DPCM
Doma Perpetual Capital Management
Florida
+$22M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.1M
3
American Century Companies
American Century Companies
Missouri
+$4.81M
4
Morgan Stanley
Morgan Stanley
New York
+$4.73M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.16M

Top Sellers

1
PCH
Polar Capital Holdings
United Kingdom
-$21.8M
2
BlackRock
BlackRock
New York
-$11.3M
3
EC
EcoR1 Capital
California
-$10.9M
4
Millennium Management
Millennium Management
New York
-$10.9M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$8.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
PWMG
226
Private Wealth Management Group
New Jersey
$2.11K – – –
HNB
227
Huntington National Bank
Ohio
$1.37K – – –
CIAM
228
Caitong International Asset Management
Hong Kong
$1.34K -$25 -1 -2%
FMII
229
Farmers & Merchants Investments Inc
Nebraska
$825 – – –
AssetMark Inc
230
AssetMark Inc
California
$799 +$761 +31 New
WANY
231
Wealthspire Advisors (New York)
New York
$722 +$688 +28 New
SC
232
Swan Capital
Florida
$696 – – –
Northwestern Mutual Wealth Management
233
Northwestern Mutual Wealth Management
Wisconsin
$644 +$614 +25 New
CT
234
Clearstead Trust
Maine
$516 – – –
Jones Financial Companies
235
Jones Financial Companies
Missouri
$379 – – –
BIA
236
Bell Investment Advisors
California
$310 – – –
SS
237
SBI Securities
Japan
$309 -$344 -14 -54%
FC
238
Financial Consulate
Maryland
$258 +$246 +10 New
BI
239
Binnacle Investments
Iowa
$206 +$196 +8 New
PCH
240
Polar Capital Holdings
United Kingdom
– -$21.8M -910,455 Closed
EC
241
EcoR1 Capital
California
– -$10.9M -457,471 Closed
SL
242
Siren LLC
Connecticut
– -$5.38M -225,000 Closed
Alyeska Investment Group
243
Alyeska Investment Group
Illinois
– -$4.8M -200,846 Closed
Marshall Wace
244
Marshall Wace
United Kingdom
– -$4.55M -190,366 Closed
Susquehanna International Group
245
Susquehanna International Group
Pennsylvania
– -$3.02M -123,087 Closed
Axa
246
Axa
France
– -$2.8M -117,285 Closed
WG
247
Winton Group
United Kingdom
– -$2.45M -102,668 Closed
Raymond James Financial
248
Raymond James Financial
Florida
– -$2.15M -90,108 Closed
Verition Fund Management
249
Verition Fund Management
Connecticut
– -$661K -27,662 Closed
Man Group
250
Man Group
United Kingdom
– -$629K -26,302 Closed
7 8 9
10
11

PCRX Hedge Fund Activity: Q3 2025 in Review

239 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2025, worth a combined $1.24B — up 2.3% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCRX positions and 30 closed out — a net gain of 7 holders — while 67 added to existing stakes and 95 trimmed.

The largest buyer was Doma Perpetual Capital Management, adding an estimated $22M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $21.8M sold.

  • 239 institutional investors held Pacira BioSciences (PCRX) as of Q3 2025, up from 233 in Q2 2025.
  • Funds reported $1.24B of Pacira BioSciences stock for Q3 2025, up 2.3% quarter-over-quarter.
  • 37 funds opened new Pacira BioSciences positions in Q3 2025 and 30 closed out, a net change of +7 holders.
  • The largest Pacira BioSciences buyer in Q3 2025 was Doma Perpetual Capital Management, an estimated $22M added.
  • The largest Pacira BioSciences seller in Q3 2025 was Polar Capital Holdings, an estimated $21.8M sold.

Based on aggregated 13F filings for Q3 2025.